Lower expression levels of ANGPTL4 mRNA are significantly associated with advanced tumor stage, poor differentiation, tumor recurrence, and decreased post-operative overall and disease-free survival of HCC patients, thereby pointing to a tumor suppressive role of ANGPTL4 [173]. This evidence concerns the gene ANGPTL4 and hepatocellular carcinoma.